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Abstract
 
We have studied the recruitment and roles of distinct dendritic cell (DC) precursors from the
circulation into 
 
Propionibacterium acnes
 
–induced granulomas in mouse liver. During infection,
F4/80
 
2
 
B220
 
2
 
CD11c
 
1
 
 DC precursors appeared in the circulation, migrated into the perisinu-
soidal space, and matured within newly formed granulomas. Recruited DCs later migrated to
the portal area to interact with T cells in what we term “portal tract–associated lymphoid tis-
sue” (PALT). Macrophage inflammatory protein 1
 
a
 
 attracted blood DC precursors to the sinu-
soidal granuloma, whereas secondary lymphoid organ chemokine (SLC) attracted mature DCs
to the newly identified PALT. Anti-SLC antibody diminished PALT expansion while exacer-
bating granuloma formation. Therefore, circulating DC precursors can migrate into a solid or-
gan like liver, and participate in the granulomatous reaction in response to specific chemokines.
Key words: dendritic cells • CC chemokine • migration • portal system • inﬂammation
 
Introduction
 
Dendritic cells (DCs)
 
1
 
 are the most potent initiators of im-
munity. Therefore, the mobilization of DCs is pivotal to
immune surveillance (1). Two established migration path-
ways of DCs are known: DC precursors, which enter the
peripheral tissues from the bloodstream to act as first-line
sentinels, and antigen-transporting DCs, which move from
the tissues to the regional LNs to promote immune re-
sponse (2–7). The trafficking of the latter is regulated by
the CC chemokine receptor (CCR)7–secondary lymphoid
organ chemokine (SLC) system operating at least in part
through afferent lymphatics (6, 7). On the other hand, DC
precursors may transmigrate the blood vessel endothelia to
enter the tissues through locally produced chemokines (3–
5). In severe inflammatory conditions, accelerated traffic of
DC precursors from the bloodstream has been suggested in
the lung (3, 8), heart, skin, kidney (9–11), and liver (12–
14). More work is needed to identify DC precursors in the
circulation and to understand their development in vivo.
Chemokines have been revealed to play central roles in
immunity by regulating the mobilization of immune cells,
not only in inflammatory but also steady-state conditions
(15–17). Selective recruitment of leukocytes to sites of in-
flammation and immune responses is based on the selective
expression of specific chemokine receptors on each type of
leukocyte. Recent investigations have highlighted the reg-
ulatory role of chemokines in immune cell dynamics
within lymphoid organs (6, 7, 16–19). Immune cells are
systematically concentrated within clearly defined “func-
tional compartments”, and their distribution is strictly reg-
ulated by chemokines (16–19). Molecular-based investiga-
tions are therefore now linked to a functional histology.
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Dendritic Cell Precursor Traffic into the Liver
 
However, compared with lymphoid tissues, functional ana-
tomical sites within other tissues are not well established.
Most chemokine studies of peripheral tissues have de-
scribed the initial event of immune cell extravasation into
inflamed tissue. However, as in the case of lymphoid or-
gans, certain compartments should also exist in nonlym-
phoid tissues, as immune cells do not evenly distribute
throughout the tissues even after transmigration.
The liver is engaged in innate host defense. Phagocytic
liver macrophages known as Kupffer cells, which directly
abut the blood stream, continually screen and capture anti-
gens from the blood (14). A small number of microorgan-
isms from the gut can also be delivered to the liver via the
portal vein, making the local host defense system quite im-
portant. Thus, the liver is considered to play essential roles
in resistance against blood-borne antigens through its spe-
cial innate defense systems. Uniquely in the liver, Kupffer
cells may also trap blood-borne DCs and translocate them
into LNs through hepatic sinusoids-lymph pathway (12,
13). Using a 
 
Propionibacterium acnes
 
–induced granulomatous
liver disease model in mice (20), we have now identified
circulating DC precursors and investigated their traffic and
needs for chemokines. A novel liver-specific immune tis-
sue, portal tract–associated lymphoid tissue (PALT), was
also established by this study.
 
Materials and Methods
 
Mice and In Vivo Treatment.
 
Specific pathogen-free female
C57BL/6 (H-2b, Ly5.2, and Ly5.1), C3H/HeN (H-2k), and
BALB/c (H-2d) mice (8–9 wk old) were obtained from CLEA
Japan Inc. Osteopetrotic (op/op) mice (4–5 wk old) and their
normal littermates (op/
 
1
 
 or 
 
1
 
/
 
1
 
) were provided by Dr. M.
Takeya (Kumamoto University, Kumamoto, Japan). Op/op mu-
tants were identified by the absence of teeth (21, 22). Mice were
injected with heat-killed 
 
P. acnes
 
 (1 mg/100 
 
m
 
l in PBS; American
Type Culture Collection 11828) via the tail vein. Granuloma for-
mation was confirmed with hematoxylin and eosin and Azan
staining of formalin-fixed 3-
 
m
 
m thick liver sections (20). Hepato-
cellular damage was determined by serum alanine transferase
(ALT) levels (20). For blocking experiments, 500 
 
m
 
g/100 
 
m
 
l in
PBS of anti-SLC polyclonal Ab (pAb) or rabbit IgG (Sigma-
Aldrich) were administered 0 and 2 d after 
 
P. acnes
 
 injection. For
in vivo proliferation assay, mice were injected with 5-bromo-2
 
9
 
-
deoxyuridine (BrdU; 500 
 
m
 
g/100 
 
m
 
l PBS; Sigma-Aldrich) 1 h
before killing. All animal experiments complied with the stan-
dards set out in the guidelines of The University of Tokyo.
 
Abs.
 
The following anti–mouse mAbs were used: CD3
 
e
 
(clone; 145-2C11), CD4 (RM4-5), CD8a (53-6.7), LFA-1 (2D7),
CD11b (M1/70), CD11c (HL3), CD14 (rmC5-3), CR1 (8C12),
CD44 (IM7), B220 (RA3-6B2), intracellular adhesion molecule
(ICAM)-1 (3E2), CD86 (GL-1), Thy1.2 (53-2.1), Gr-1 (RB6-
8C5), Pan-NK cell (DX5), peripheral node addressin (PNAd) car-
bohydrate epitope (MECA-79; all from BD PharMingen), F4/80
(CI:A3-1), DEC-205 (NLDC-145), MHC class II (ER-TR3),
murine metallophilic macrophages (MOMA-1; all from BMA
Biomedicals), CD11c (N418; Serotec), M342 (Dr. R.M. Stein-
man, Rockefeller University, New York, NY), FDC-M1 (Dr.
M.H. Kosco-Vilbois, Geneva Biomedical Research Institute,
Geneva, Switzerland), anti–
 
P. acnes
 
 (Dr. Y. Eishi, Tokyo Medical
 
and Dental University, Tokyo, Japan), and Ly5.2 (AL1-4A2; Dr.
T. Kina, Kyoto University, Kyoto, Japan). A rabbit pAb to bovine
type IV collagen (LSL Co.) was used to outline hepatic sinusoids
(12). As secondary Abs, an alkaline phosphatase (ALP)-labeled
anti–rat or rabbit IgG (Jackson ImmunoResearch Laboratories), a
horseradish peroxidase–labeled anti–rat Ig (Biosource Interna-
tional), an horseradish peroxidase–labeled goat F(ab
 
9
 
)
 
2
 
 to rabbit
IgG (Cappel), and an ALP-conjugated anti–hamster IgG (Cedar-
lane) were used. For macrophage inflammatory protein (MIP)-1
 
a
 
,
a goat pAb to anti–MIP-1
 
a
 
 (R&D Systems) was used (23). For
SLC, we produced rabbit anti–mouse SLC pAb (24, 24a).
 
Immunostaining.
 
Single or double immunostaining was per-
formed by indirect immunoalkaline phosphatase or immunoper-
oxidase methods (12). For triple immunostaining, acetone-fixed
6-
 
m
 
m fresh frozen tissue sections were doubly immunostained
using 3,3
 
9
 
-diaminobenzidine (DAB; Wako) substrate solution
and ALP substrate kit II (Vector blue; Vector Laboratories). After
further fixation with 1% glutaraldehyde (Nakarai) in PBS for 9
min, they were reacted with the third Abs to BrdU or 
 
P. acnes
 
 us-
ing a BrdU staining kit (Zymed Laboratories) or M.O.M. immu-
nodetection kit (Vector Laboratories), respectively, and were col-
ored red with Vector Red (Vector Laboratories). Slides were
counterstained with Mayer’s hematoxylin.
 
Enrichment of DCs from Nonparenchymal Cells.
 
Nonparenchy-
mal cells (NPCs) were prepared as described by Kawada et al.
(25), with some modifications. Liver was perfused in situ via the
portal vein with liver perfusion medium (LPM; 137 mM NaCl,
5.4 mM KCl, 0.6 mM NaH2PO4, 0.8 mM Na2HPO4, 10 mM
Hepes, 3.8 mM CaCl2, 4.2 mM NaHCO3, and 5 mM glucose,
pH 7.35) for 10 min, followed by collagenase solution (1 mg/ml
in LPM; Wako) for 5 min at 37
 
8
 
C at a flow rate of 4 ml/min. Af-
ter perfusion, the liver was excised and incubated in collagenase
solution containing 20 
 
m
 
g/ml DNase (Boehringer) at 37
 
8
 
C for 30
min with constant stirring. Cell suspensions (5 ml in RPMI 1640
supplemented with 10% heat-inactivated FCS containing 2.5
mM EDTA) were layered onto 5-ml columns of 16.8% Nyco-
denz (Nycomed Pharma). After centrifugation (2,500 rpm for 20
min at room temperature), the interface was used as NPCs. Flow
cytometric immunofluorescence analyses for CD11c, DEC-205,
and F4/80 of freshly isolated NPCs were performed and CD11c
 
1
 
cells were sorted using an Epics Elite ESP cell sorter (Beckman
Coulter) as described previously (20, 26).
Low density (LD), DC-enriched cells were prepared as re-
ported by Woo et al. (27), with slight modifications. NPCs (2 
 
3
 
10
 
6
 
/ml) were placed in 10% FCS-RPMI 1640 supplemented
with 15 ng/ml GM-CSF (R&D Systems), and cultured overnight
(18 h). Nonadherent cells (3 ml in the medium) were layered
onto 5-ml columns of 14.5% Nycodenz. After centrifugation
(1,850 rpm for 20 min at room temperature), the interface con-
taining LD cells was carefully collected.
 
Cell Culture.
 
Peripheral blood (0.8 ml) was obtained by car-
diac puncture under ether anesthesia. After density separation
(Lympholyte-Mouse; Cedarlane), immunofluorescence analyses
were performed and B220
 
2
 
CD11c
 
1
 
 cells were sorted (26). Re-
analysis of the sorted population showed purity 
 
.
 
99%. Purified
B220
 
2
 
CD11c
 
1
 
 cells (10
 
5
 
 cells/ml) were incubated in IMDM
(GIBCO BRL) supplemented with 20% FCS, penicillin G (100
U/ml), and streptomycin (100 
 
m
 
g/ml) in the presence of GM-
CSF (4 ng/ml). Optimal conditions were maintained every 2–3 d
by replacing 50% of the medium with fresh medium containing 4
ng/ml GM-CSF. After 5–7 d, the cultured cells were further in-
cubated with TNF-
 
a
 
 (50 ng/ml) in addition to GM-CSF on
type I collagen-coated plates (IWAKI) for 3–4 d. 
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Allogeneic Mixed Leukocyte Reaction.
 
The one-way mixed leu-
kocyte reaction (MLR) was performed in 96-well plates using the
Premix WST-1 cell proliferation assay system (Takara Biomedi-
cals), according to the manufacturer’s instructions. C57BL/6
mouse liver- and spleen-derived LD cells were incubated with
mitomycin C (20 
 
m
 
g/ml) for 30 min at 37
 
8
 
C, then cocultured
(3 
 
3 
 
10–3 
 
3
 
 10
 
4
 
 cells/100 
 
m
 
l/well) with nylon-wool passed
spleen T cells (4 
 
3
 
 10
 
5
 
 cells/100 
 
m
 
l/well) from C3H/HeN mice
for 72 h. 4 h before the end of culture, WST-1 (20 
 
m
 
l) was added
and the absorbance (450–650 nm) was measured. For peripheral
blood B220
 
2
 
CD11c
 
1
 
 cells, highly purified spleen CD4
 
1
 
 T cells
from BALB/c mice were used as the responder cells and prolifer-
ation was determined using an MTT assay (5 mg/ml, 15 
 
m
 
l/well;
Sigma-Aldrich) as described earlier (26).
 
Reverse Transcription PCR.
 
Total RNA was isolated from
liver specimens and 2 
 
3
 
 10
 
5
 
 sorted blood or liver CD11c
 
1
 
 cells
using RNazol B
 
 
 
(Biotex Laboratories, Inc.) and reverse tran-
scribed (20). Thereafter, cDNA was amplified using the ABI
7700 sequence detector system (Applied Biosystems) with a set of
primers and probes corresponding to MIP-1
 
a
 
, SLC, CCR1,
CCR5, CCR7, and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) as described previously (20, 23, 24). The primers for
SLC were: 5
 
9
 
-GGCTATAGGAAGCAAGAACCAAGT-3
 
9
 
 and
5
 
9
 
-TCAGGCTTAGAGTGCTTCCG-3
 
9
 
. The probes were as
follows: 5
 
9
 
-CCCATCCCGGCAATCCTGTTCTTA-3
 
9
 
 for
SLC, and 5
 
9
 
-ATCACCATCCAAGTGGCCCAGATGGT-3
 
9
 
for CCR7. Others were as described earlier (20, 23, 24).
 
Chemotaxis Assay.
 
Freshly isolated PBLs and NPCs (8 
 
3
 
10
 
5
 
/120 
 
m
 
l in RPMI 1640 plus 0.25% BSA) obtained from 
 
P. ac-
nes
 
–primed mice at day 7 were loaded into murine type IV col-
lagen-coated transwells (3-
 
m
 
m pore size; Becton Dickinson),
which were placed in a 24-well tissue culture plate containing
500 
 
m
 
l of the medium supplemented with or without 100 ng/ml
of MIP-1
 
a
 
, macrophage-derived chemokine, IFN-
 
g
 
–inducible
protein (IP)-10 (R&D Systems), or SLC (24). After an incubation
period of 4 h at 37
 
8
 
C, cells in the bottom of each well were col-
lected and counted with a hemocytometer. After immunostain-
ing for CD11c, the absolute number of migrated CD11c
 
1
 
 cells
was determined by multiplying the total migrated cell number by
the fraction of CD11c
 
1
 
 population.
 
DC Trafficking Assay.
 
Freshly isolated PBLs obtained from 
 
P.
acnes
 
–primed Ly5.2 mice at day 5 were incubated with mAb to
CD11c for 30 min, followed by goat anti–hamster IgG-labeled
magnetic microbeads (20 
 
m
 
l/10
 
7
 
 cells; Miltenyi Biotech) for 45
min; CD11c
 
1
 
 cells were then isolated using MACS system ac-
cording to the manufacturer’s instructions. The purity of the
CD11c
 
1
 
 cell populations was 92% or more as confirmed by im-
munofluorescence flow cytometry. Isolated CD11c
 
1
 
 cells (2 
 
3
Figure 1. Existence of DCs in hepatic granulomas. Day 7 after P. acnes injection. CD11c (a), DEC-205 (b), M342 (d), MHC class II (e), F4/80 (red;
f), type IV collagen (brown; a, b, and d–g). (c) DEC-2051 (brown) cells were clustered with BrdU1(red) CD41(blue) cells in the granuloma. (g) Type IV
collagen alone was a negative control. Original magnifications: (a and b) 3100; (inset, c–g) 3400.38 Dendritic Cell Precursor Traffic into the Liver
106 cells/200 ml in PBS) were injected intravenously into the tail
vein of P. acnes–primed congeneic Ly5.1 mice at day 5. 1, 6, and
24 h later, recipient liver and hepatic LNs were sampled. After
blocking endogenous peroxidase (0.3% hydrogen peroxide in
PBS) and avidin/biotin (Avidin/Biotin blocking kit; Vector Lab-
oratories) activity, double immunohistochemical staining for
Ly5.2 and B220/CD4 was performed. In some experiments,
anti–MIP-1a or SLC pAb and control IgG (200 mg/100 ml PBS)
were injected just before cell transfer.
Statistical Analysis. Differences were evaluated using the Stu-
dent’s t test. P values ,0.05 were considered to be statistically
significant.
Results
Identification of DCs in Hepatic Granulomas. Mice ex-
posed to P. acnes by day 7 developed numerous granulomas
in the liver (20; Fig. 1, a–g). F4/801 cells including Kupffer
cells and inflammatory macrophages (28) were evenly dis-
tributed throughout the granulomas (Fig. 1 f), whereas
CD41 cells localized in the periphery (Fig. 1 c). In addi-
tion, cells with the markers of DCs (1, 19, 26), such as
CD11c, DEC-205, M342, MHC class II, and CD86, were
also distributed within granulomas (Fig. 1, a–e). We then
Figure 2. Identification of
DCs in hepatic granulomas. (a)
Phenotype of granuloma-derived
NPCs and LD cells on day 7. (b)
Primary allogeneic MLR of
granuloma-derived liver LD
cells, normal liver LD cells,
spleen LD cells, and responder
cells alone. Three mice per
group and 1,000 total cells/smear
were examined. Representative
data from six experiments.
Mean 6 SD (n 5 3).
Figure 3. Kinetics of DCs in
granuloma formation. (a) 15
mm2 of stained cryosections
were examined for the presence
of CD11c1 or DEC-2051 cells.
Densely labeled cells were ana-
lyzed using a grid micrometer
(reference 11). The number of
grid intersections overlying posi-
tively labeled cells was counted.
Final results were presented as
the proportion of the number of
positive intersections to the total
number of grid intersections. (c)
Untreated mice as control. (b)
The absolute numbers of
CD11c1 NPCs (white bars) and
DEC-2051CD11c1 NPCs (solid
line). Representative data from
six independent experiments.
Mean 6 SD (n 5 10). (c) DEC-
2051 (red) cells of sorted
CD11c1 NPCs on day 4. (d)
Cytosmears of NPCs on day 7.
Note that CD11c1 cells (red)
and F4/801 macrophages
(brown) are clearly distinguish-
able. Original magnification: (c
and d) 31,000.39 Yoneyama et al.
investigated LD cells recovered on Nycodenz gradients
from the NPC fraction of a granulomatous liver. A major-
ity of LD cells actually had features of DCs, such as an ec-
centric irregular nucleus and a cytoplasmic membrane with
ruffled projections (data not shown). The cells were MHC
class IIhigh, CD11c1, DEC-2051, ICAM-11, CD3e2,
B2202, CD8a2, Gr-12, and expressed moderate levels of
CD86, LFA-1, and CD11b (Fig. 2 a). In a functional study,
they induced considerable proliferation of allogeneic T
cells in vitro, compared with normal liver- and spleen-
derived LD cells (Fig. 2 b), demonstrating that the granu-
loma contained functionally mature DCs. Moreover,
DEC-2051 cells were in close contact with CD41 T cells,
many of which were in a proliferative stage, as evidenced
by in situ BrdU labeling (Fig. 1 c). This suggests that DCs
in the granuloma have potent antigen-presenting function
and can activate T cells in situ.
Rapid Accumulation of CD11c1 DCs in the P. acnes–primed
Liver. Small cell clusters were primarily observed in the
sinusoidal, not in the portal, areas by 1 h after P. acnes in-
jection. These increased in size by 3 d after P. acnes injec-
tion, then developed into mature granulomas by day 7. We
next investigated the kinetics of DC accumulation in gran-
ulomas. In steady state, small numbers of CD11c1 or
DEC-2051 interstitial DCs could be found, predominantly
within the portal areas (27; Fig. 3 a). However, in the early
phase of P. acnes injection (1 h–3 d) a new influx of
CD11c1 cells appeared in the sinusoidal area and selectively
localized in developing granulomas composed of small cell
clusters (Fig. 3 a). Subsequently, DEC-2051 cells (Fig. 3 a)
as well as CD41 cells (data not shown) could be found in
the developing granuloma beginning at 2–3 d after P. acnes
treatment. In the late phase (3–7 d), CD11c1 cells were
distributed not only within granulomas but also diffusely
into the sinusoidal area (Fig. 1 a and Fig. 3 a), whereas
DEC-2051 cells were confined to the center of granulomas
(Fig. 1 b and Fig. 3 a).
CD11c1 NPCs also increased in number from 1 h after
P. acnes injection and reached a peak by day 3 (Fig. 3 b).
The expression of DEC-205 by CD11c1 NPCs was ob-
served beginning at day 3 and gradually increased in num-
ber (Fig. 3, b and c), similar to their distribution pattern
Figure 4. Emergence of CD11c1 DC precursors in the circulation. (a) The absolute numbers of CD11c1 and F4/801 cells were determined by mul-
tiplying the total PBL number per ml by the fraction of CD11c1F4/802 and F4/801CD11c2 population. (b) CD11c1 PBLs (red) on day 7. (c) Gate for
B220-CD11c1 subsets at day 5 by direct staining with PE-labeled anti-B220 mAb and FITC-labeled anti-CD11c mAb. (d) Freshly sorted B2202CD11c1
cells at day 5, stained with Giemsa. (e) Phenotype of freshly sorted and 10-d cultured B2202CD11c1 cells. (f) Primary allogeneic MLR of freshly sorted,
10-d cultured B2202CD11c1 cells, and spleen DCs. Representative data from three independent experiments. Mean 5 SD (n 5 3). (g) MHC class II1
(brown) 8-d cultured B2202CD11c1 cells. (h) P. acnes (brown)–laden CD11c1 PBLs (day 1). Original magnifications: (b, d, g, and h) 3400.40 Dendritic Cell Precursor Traffic into the Liver
(Fig. 1 b and Fig. 3 a), suggesting that CD11c1 NPCs
lodged in the granulomas acquired DEC-205 phenotype
during maturation time. Notably, granuloma-derived
CD11c1 NPCs were negative for F4/80 (Fig. 3 d)
throughout, indicating that they were distinct from Kupffer
cells, macrophages, and mature monocytes.
Identification of Circulating DC Precursors. Expansion of
CD11c1 cells (Fig. 3 b) at granulomatous sites (Fig. 3 a)
presumably depended on recruitment of CD11c1 cells
from the circulation. CD11c1 cells were not found in the
blood in the steady state, but rapidly increased to a peak
level (15–20%) by day 1 of infection (Fig. 4, a and b). As
Figure 5. Entry, proliferation, and exit of DCs in
the liver. (a) Primary cell cluster between CD11c1 cells
(arrowheads; blue) and P. acnes (red)–laden F4/801
cells (arrows; brown) in the sinusoidal wall (1 h). (b) P.
acnes (red)–laden CD11c1 cells (blue) in the sinusoid (6
h). (c) The labeling index of CD11c1 NPCs by 1 h
BrdU labeling. (d) Cytosmears of BrdU1 (red)
CD11c1 (blue) NPCs on day 4. (e) DEC2051DC (ar-
rows; brown) as well as BrdU1(red) CD41(blue) cells
(arrowheads) leave the liver via dilated afferent lym-
phatics (day 7). Original magnifications: (a, b, d, and e)
3400. B, bile duct; P, portal vein; L, lymphatic; aster-
isk, nonspecific staining of bile ducts.41 Yoneyama et al.
Figure 6. Formation of PALT. (a–f) Immunohistochemistry for B220 (a, red; type IV
collagen, brown), FDC-M1 (b, brown), CR1 (c, brown), CD4 (d, blue; DEC205,
brown; BrdU, red), PNAd (e, brown), and MOMA-1 (f, red) in PALT (day 7). Origi-
nal magnifications: 3400. B, bile duct; P, portal vein; L, lymphatic. (g) Kinetics of
BrdU1CD41 cells in PALT and the sinusoidal granuloma (GR). Mean 6 SD (n 5 6).
Asterisk, P , 0.05.42 Dendritic Cell Precursor Traffic into the Liver
blood CD11c1 cells were negative for F4/80, CD3e, Gr-1,
and a pan NK cell marker (data not shown), but had
low levels of B220 (Fig. 4 c), we sorted B2202CD11c1
cells from PBLs at day 5 (Fig. 4 c). Freshly isolated
B2202CD11c1 cells exhibited monocyte-like morphology
(Fig. 4 d), and possessed neither the phenotypic markers of
DCs, such as MHC class II, DEC-205, and CD86 (Fig. 4 e)
nor DC function in allostimulation assays (Fig. 4 f). How-
ever, when B2202CD11c1 cells were cultured with GM-
CSF alone for 5 d, and subsequently incubated with GM-
CSF and TNF-a on type I collagen-coated plates for 3–4 d,
they expressed the phenotype of DCs (Fig. 4, e and g)
and acquired functional alloantigen-presenting capability
(Fig. 4 f). These observations indicate that blood
B2202CD11c1 cells represent DC precursors. In addition,
z10% of freshly isolated blood B2202CD11c1 cells at day
1 were positive for P. acnes as evidenced by immunostain-
ing of cytosmears (Fig. 4 h), indicating that these cells also
had phagocytic capability.
These CD11c1 DC precursors may migrate to the
perisinusoidal space from an early time and inhabit the de-
veloping granulomas being surrounded by P. acnes–laden
macrophages (Fig. 5 a). Occasionally, P. acnes–laden
CD11c1 DCs were also detected in the sinusoidal area (Fig.
5 b), which is considered to be the site of DC entry. Some
recruited CD11c1 DCs possessed proliferating capability in
the liver (Fig. 5, c and d). Altogether, we propose that
blood F4/802B2202DEC-2052CD11c1 cells are DC pre-
cursors, which enter the liver and gradually mature into
functional MHC class II1DEC-2051CD11c1 antigen-pre-
senting cells within granulomas. Subsequently, DCs may
undergo translocation from the liver to the hepatic lymph
(13). DEC-2051 DCs were found within the afferent lym-
phatics located in the portal area (Fig. 5 e), suggesting this
area to be the site of DC exit.
Formation of PALT. Immunohistochemistry revealed
that the P. acnes–induced portal infiltrate contained B2201
B cell aggregations (Fig. 6 a), which were rarely seen in the
sinusoidal area. Follicular DC (FDC)-reactive markers (29),
FDC-M11 and CR11 cells, were also found in these portal
B cell aggregates (Fig. 6, b and c) like B cell follicles, al-
though typical germinal centers were not observed. In ad-
dition, CD41 T cells were found between B cell follicles
and bile ducts (Fig. 6 d). The pattern was distinct from
CD41 T cells in sinusoidal granulomas, which localized in
the periphery of the granuloma (Fig. 1 c). The portal
CD41 T cell clusters were associated with high endothelial
venule (HEV)-like vessels as revealed by PNAd (30) stain-
ing (Fig. 6 e). On the outer rim of these B and T foci, mac-
rophages were recognized by MOMA-1 (Fig. 6 f), ER-TR9,
and antisialoadhesin Ab (data not shown). Accordingly, the
portal infiltrates actually resembled the organization of lym-
phoid tissue in peripheral LNs, which contain B cell folli-
cles, T cell areas, and macrophages. Therefore, P. acnes ad-
ministration induced “tertiary” portal lymphoid tissue as
well as sinusoidal granulomas.
The relationship between sinusoidal granulomas and the
portal lymphoid tissues was examined by in situ BrdU
staining. Although BrdU1CD41 T cells were not detected
within the developing granuloma until 3 d after P. acnes in-
Figure 7. Migration potentials of DC precursors and
liver DCs. (a) Real-time quantitative PCR analysis of
chemokine receptor mRNA expressions on freshly isolated
blood and liver CD11c1 cells from P. acnes–primed mice at
day 7. Each amount was normalized to the level of each
glyceraldehyde-3-phosphate dehydrogenase. The final rel-
ative values were expressed relative to the calibrators; nor-
malized amount of NPCs for CCR1 and CCR5, and of
PBLs for CCR7. (b) Chemotaxis of freshly isolated blood
and liver CD11c1 cells at day 7. NC, medium alone as
negative control. Representative data from three indepen-
dent experiments. Mean 6 SD (n 5 3).43 Yoneyama et al.
jection, such cells were already observed in the portal area
from day 1 (Fig. 6 g). This indicates that CD41 T cell pro-
liferation first occurred in the portal lymphoid tissues fol-
lowed by the sinusoidal granulomatous areas. These obser-
vations suggested that the portal area was the primary site
of immune responses to P. acnes locally in the liver,
whereas the sinusoidal area appeared to be an effector site.
We therefore propose here the concept that PALT plays a
pivotal role in the immune response in an inflamed liver.
Migration Potential of DC Precursors and Liver DCs. On
the presumption that transmigration of DCs was chemo-
kine mediated, we examined chemokine receptor mRNA
expression in freshly isolated blood and liver CD11c1 cells
and their migration potential. Blood CD11c1 DC precur-
sors predominantly expressed CCR1 and CCR5, whereas
these receptors were downregulated in liver CD11c1 cells.
Only CCR7 was upregulated in liver CD11c1 cells com-
pared with blood DC precursors (Fig. 7 a). In chemotaxis
assays, blood CD11c1 DC precursors showed a significant
chemotactic response toward MIP-1a, and had a weak re-
sponse to SLC. In contrast, liver CD11c1 cells acquired a
migratory capacity toward SLC, although they still re-
sponded to MIP-1a (Fig. 7 b).
MIP-1a was weakly expressed in the sinusoidal endo-
thelial cells and Kupffer cells in untreated liver, but was pro-
duced at high levels in the sinusoidal granulomas of in-
flamed liver (20; Fig. 8 a). On the other hand, SLC was
constitutively produced by the portal lymphatic endothelia
(31) and connective tissue stroma (Fig. 8 b). Furthermore,
the expression levels of SLC mRNA in the liver were sig-
nificantly increased after P. acnes injection (Fig. 8 c).
Chemokine Regulation of DC Precursor Trafficking into the
Liver. To test whether blood DC precursors actually enter
the liver, we adoptively transferred blood CD11c1 cells de-
rived from Ly5.2 mice into P. acnes–primed recipient con-
geneic (Ly5.1) mice. There seem to be at least two steps in
DC trafficking into the liver. The first step was immediately
after transfer (1 h) with CD11c1 cells located predomi-
nantly in the sinusoidal granulomatous area (Fig. 9, a and b).
The second step began 6 h after transfer with a significant
increase in CD11c1 cells in the portal area (Fig. 9 a). These
DC precursors preferentially accumulated in the T cell area
(Fig. 9 c), but not in the B cell follicle (Fig. 9 d) of PALT.
CD11c1 cells were also located in the paracortex of the he-
patic LNs (Fig. 9 e) by 24 h, indicating that some of them
underwent a sinusoid-lymph translocation and accumulated
in the T cell area of the regional LNs (13). We next in-
jected the recipient mice with neutralizing anti–MIP-1a
pAb just before cell transfer. This inhibited trafficking of
CD11c1 DC precursors almost completely within all com-
partments in the liver (Fig. 9 a). Presumably, this was due to
a failure of at least the first step of DC precursor migration.
Thus, MIP-1a plays crucial roles in blood DC precursor
trafficking into the liver. On the other hand, anti-SLC pAb
Figure 8. Distinct expression pattern of chemokines in the liver. (a) Production of MIP-1a (red) by
granuloma-composed cells (day 7). Type IV collagen (brown). (d) Production of SLC (red) by lym-
phatic endothelia and tissue stroma in the portal area (day 7). Original magnifications: 3400. P, portal
vein; L, lymphatic. (c) SLC mRNA expression level in the liver. A normalized SLC value of control
(C) liver was designated as the calibrator. Mean 6 SD (n 5 3). Asterisk, P , 0.05.44 Dendritic Cell Precursor Traffic into the Liver
injection showed almost no effect on the entry of DC pre-
cursors into the granulomatous area. Anti-SLC pAb did in-
hibit accumulation of CD11c1 cells in the portal areas (Fig.
9 a). This suggests a selective blockade of the second migra-
tory step of recruited DCs by anti-SLC pAb.
SLC Regulates Trafficking of DCs in Forming PALT. To
define the biological role of SLC in granuloma formation,
we investigated the effect of anti-SLC pAb on granuloma-
associated liver injury. Mice were injected with anti-SLC
pAb 0 and 2 d after P. acnes treatment. At day 7, anti-SLC
pAb unexpectedly enhanced sinusoidal granuloma forma-
tion and hepatocellular damage (Fig. 10, a and b). In some
cases, limited hepatocellular necrosis was observed sur-
rounding the granulomatous area (Fig. 10 a). CD11c1
NPCs were increased in number by treatment with anti-
SLC pAb (Fig. 10 c), but they decreased in the portal area.
This may be due to an interference with movement of
CD11c1 DCs into the portal area, but without any affect
on the entry of blood CD11c1 DC precursor into the liver
sinusoid. Thus, CD11c1 cells selectively increased in num-
ber in the sinusoidal granulomatous area and sometimes at
the margin of the necrotic area. In contrast, BrdU1 and
B2201 cells were reduced in number (Fig. 10 d) and the
HEV-like vessels could not be seen in the portal area (data
Figure 9. Chemokines regulate DC precursor trafficking into the liver. (a) Effect of anti–MIP-1a and anti-SLC pAbs on DC trafficking. 15 mm2 of
stained recipient cryosections were examined for the presence of donor cells within the sinusoidal granulomatous (GR), sinusoidal nongranulomatous
(NGR), and PALT areas. Representative data from three independent experiments. Mean 6 SD (n 5 3). Asterisk, P , 0.05. (b–e) Donor (Ly5.2)-
derived CD11c1 cells (brown) in the sinusoidal granulomas (b, arrows; 1 h), the portal area (c and d, arrows; 6 h), and the paracortex in the hepatic LN
(e, arrows; 24 h). B220 (d and e) or CD4 (b, inset, and c; blue). Original magnifications: (b) 3100; (b, inset) 3400; (c–e) 3200. P, portal vein; L, lym-
phatics; PC, paracortex.45 Yoneyama et al.
not shown), supporting the inhibitory role of anti-SLC
pAb on induction of PALT. This means anti-SLC pAb
treatment reduced PALT expansion, but enhanced sinusoi-
dal granuloma formation. BrdU1 and DEC-2051 cells
were also decreased in number in the T cell areas of hepatic
LNs, after anti-SLC Ab treatment (Fig. 10 e), suggesting
that mature DEC-2051 DCs failed to migrate to the re-
gional LNs via draining lymphatics and that naive CD41 T
cells also failed to enter the LNs via HEVs from the circula-
tion (6). As a consequence, cluster formation between ma-
ture DCs and naive T cells within PALT and regional LNs
were decreased, leading to impaired primary T cell prolif-
Figure 10. Effect of anti-SLC pAb on liver injury and PALT. (a) CD11c1 cells (red) surround the necrotic area at 7 d after treatment with anti-SLC
pAb. Type IV collagen (brown). Original magnification: 3100. (b) Serum ALT levels on day 7. (c) The absolute numbers of CD11c1 NPCs. (d and e)
The numbers of BrdU1CD41 and B2201 cells in the PALT and sinusoidal granulomatous (GR) area, and BrdU1 and DEC2051 cells in the paracortex
of hepatic LNs determined by 15 mm2 stained cryosections on day 7. T cell area of hepatic LNs was defined by B220 or CD3e staining. (f) The absolute
numbers and primary allogeneic MLR of LD-DCs from anti-SLC pAb and control Ab–treated mice (day 7). Representative data from six independent
experiments. Mean 6 SD (n 5 3). Asterisk, P , 0.05.46 Dendritic Cell Precursor Traffic into the Liver
erative responses. Most of the granuloma-derived LD DCs
obtained from anti-SLC pAb–treated liver showed low al-
lostimulatory capability (Fig. 10 f), suggesting that immobi-
lized DCs within granulomas did not undergo functional
maturation. The reduction in number of BrdU1CD41 T
cells in the sinusoidal area (Fig. 10 d) also supported this
idea. Therefore, effective immune responses were impaired
not only locally but also at regional LN levels.
1 mo after P. acnes injection, granulomas disappeared al-
most completely in control Ab-treated mice, but persisted
in anti-SLC pAb–treated mice together with elevation of
serum ALT level (Fig. 11, a and b). Collectively in sum-
mary, anti-SLC pAb immobilized CCR71CD11c1 DC in
the granuloma sites, impaired the capacity of the host im-
mune responses to eliminate P. acnes, and resulted in the
persistence of granulomas.
Emergence of Inflammation-associated Circulating CD11c1
DC Precursors in Monocyte-deficient Mice. Finally, to estab-
lish that CD11c1 DC precursors are not derived from
monocytes, we investigated whether CD11c1 cells appear
both in the circulation and in the hepatic granulomas using
op/op mice that lack M-CSF–dependent monocytes. F4/
802CD11c1 cells defined as DC precursors appeared in the
circulation, even in op/op mice (Fig. 12 a). Although the
total number of CD11c1 cells was decreased in op/op
mice, their proportion in the blood was similar to that of
control littermate mice. Moreover, P. acnes injection in-
duced granulomas containing CD11c1 cells in situ even in
op/op mice, although their number and the size of the
granulomas were decreased (Fig. 12, b and c). These results
support the notion that F4/802CD11c1 DC precursors
identified in this study originate from cells distinct from
monocytes.
Discussion
Granuloma formation is a hallmark of persistent infection
(32). P. acnes is considered to be the cause of sarcoidosis
(33). Experimentally, this anaerobic bacterium also leads to
granulomas in the lung and liver (20, 33). Our data indicate
that granuloma formation involves not only a macrophage-
based component but also a DC-induced adoptive re-
sponse.
We have demonstrated in this study murine DC precur-
sors, defined as CD11c1F4/802DEC-2052MHC class II2
cells, in the peripheral blood, which appeared rapidly after
P. acnes injection. Peripheral blood DC precursors can be
functionally classified into three groups in human
CD11c1HLA-DRhigh DCs (1, 34, 35), CD11c2HLA-
DRhigh DCs (1, 36, 37), and monocytes (1, 38). In mice, in
contrast, recognition of DC precursors in the circulation
has been difficult because they are MHC class II negative
(10, 39; Fig. 4 e). Recently, mouse inflammatory mono-
cytes were shown to differentiate into DCs after several
days in vivo (40). In this experimental situation, neither
monocyte-derived DC precursors nor monocytes ex-
pressed CD11c. In contrast, in this study, CD11c1 cells
rapidly appeared both in the circulation and in the liver
from an early stage (within 6 h) after P. acnes injection (Fig.
3 b and Fig. 4 a), and some of the CD11c1 cells in the liver
showed significant proliferating activities (Fig. 5 c). Mono-
Figure 11. Anti-SLC pAb prolongs granuloma formation. (a) Serum
ALT levels on day 28. (b) The number and the size of granuloma (GR)
on day 28. Representative data from three independent experiments.
Mean 6 SD (n 5 6). Asterisk, P , 0.05.
Figure 12. Emergence of CD11c1 cells both in the circulation and in the liver in P. acnes–primed monocyte-deficient mice. (a) The absolute numbers
of CD11c1F4/802 PBLs. (b) The number (bars, left y axis) and the size (lines, right y axis) of granuloma (GR). Mean 6 SD (n 5 3). (c) CD11c1 cells
(red) in a granuloma of op/op mouse on day 7. Original magnifications: 3100. All granulomas present in the P. acnes–primed op/op mice were CD11c1
during disease course.47 Yoneyama et al.
cytes are considered to be nonproliferating stage cells, and
monocytes cultured to undergo differentiation into DCs
usually do not contain cycling cells (41). F4/801CD11c2
cells also emerged in the circulation, but these cells never
expressed CD11c throughout (Fig. 4 a), similar to the
above study (40). In monocyte-deficient op/op mice,
blood CD11c1 cells rapidly appeared 1 d after P. acnes in-
jection (Fig. 12 a) and these cells constituted granuloma
(Fig. 12, b and c). Although P. acnes injection may induce
some cytokines (20) that substitute for M-CSF activity
even in op/op mice (42, 43), 24 h is too short and very un-
likely for these cytokines to differentiate a large number of
monocytes into CD11c1 DC precursors. We therefore
consider that CD11c1 precursors are distinct from inflam-
matory monocytes (40), and blood F4/801CD11c2 cells,
on the other hand, are activated monocytes.
Interaction with endothelial cells is required for blood
leukocytes to extravasate into tissues (5). Circulating DC
precursors may also transmigrate through the sinusoidal
wall in the liver to participate in granuloma formation. The
sinusoidal wall contains several distinct cell types: endothe-
lial cells, Kupffer cells, a few pit cells located in the hepatic
sinusoid, and Ito cells in Disse’s space. The sinusoidal wall
is the principal site for capturing blood-borne microorgan-
isms (44), and most inflammatory infiltrates, including P.
acnes–induced granulomas, are initially formed in Disse’s
space (44, 45). Uniquely in the liver, Kupffer cells predom-
inantly interact with blood-borne DCs (13) and enable
them to extravasate through endothelial pores to enter
Disse’s space (46), then help them translocate into hepatic
lymph (13). As Kupffer cell–derived MIP-1a may recruit
circulating DC precursors (Fig. 7 b), interaction of DC
precursors and P. acnes-laden Kupffer cells (Fig. 5 a) may
initiate to form granuloma in Disse’s space. Recruited
CD11c1 DC precursors themselves produce MIP-1a (data
not shown) to induce another wave of DC precursor mi-
gration into the inflamed liver.
After entering the sinusoidal wall, DC precursors may
undergo further maturational processes. Some DCs subse-
quently move through draining lymphatic pathways to re-
gional hepatic LNs. During this migration, DCs must first
pass the portal tract, as lymphatic capillaries are mostly lo-
cated in this area (14). SLC on the lymphatic capillaries
may attract DCs (Fig. 7 b) and induce PALT expansion.
Part of the DCs remains within the sinusoidal developing
granulomas. In association with the maturation of the re-
tained DCs, proliferating CD41 T cells appear in granulo-
mas (Fig. 1 c), suggesting that recently activated memory
CD41 T cells home to the granulomatous areas from re-
gional LNs via efferent lymphatics and circulation. MIP-
1a, IFN-g–inducible protein 10 (IP-10), and monokine
induced by IFN-g (Mig) may recruit CCR51 or CXCR31
Th1–type CD41 T cells into the liver (20). Thus, activated
DCs maintain the local inflammatory reaction to sequester
microorganisms within a granuloma consisting of clusters
of DCs, macrophages, and CD41 T cells.
How do DCs migrate to the portal area? DCs may ex-
travasate through the sinusoidal wall after binding to
Kupffer cells. Two possible systems for transferring blood-
borne antigens from the sinusoidal area to the portal area
are possible. First, DC precursors may phagocytose antigens
in the sinusoidal wall during interaction with Kupffer cells.
This pattern is similar to that of M cells and subepithelial
dome DCs in Peyer’s patches (19, 47). As Disse’s space is
continuous with the tissue space of the portal area (48), af-
ter capturing antigens, activated DCs may extravasate and
exit the hepatic lobule (Fig. 5 e). SLC produced in the por-
tal area may attract these DCs, in addition to a passive
movement due to the negative pressure produced by
lymph flow (14). Delay of emergence of DC precursors in
the portal area (Fig. 9 a) by anti-SLC pAb supports this in-
terpretation. Hence, it is likely that DCs within Disse’s
space move from the sinusoidal unit to PALT. Second, an-
tigens may be also transported in a free form in tissue fluid
flowing through Disse’s space from the sinusoidal area to
the portal area.
Normally, cellular infiltration in the portal area is rather
sparse. In contrast, increased “portal infiltration” has been
described in pathological states (14). Therefore, PALT is an
inducible structure similar to bronchus-associated lymphoid
tissue (29). The liver is also a site for production of Ab, es-
pecially secretory IgA which is transported into bile duct.
The location between bile duct and PALT resembles that
between salivary gland and duct-associated lymphoid tissue
(49). PALT may act as first line defense of the lymphatic
pathway as well as sites of local immune induction. More-
over, the loss of PALT was accompanied by more ad-
vanced hepatocellular damage in the sinusoidal area (Fig.
10). These observations indicate that the balance between
protective PALT and the injurious sinusoidal granuloma
would determine the disease outcome.
In our model, the treatment with anti-SLC pAb inhib-
ited the maturation of recruited DC precursors at granulo-
matous sites, although the number of DCs in the liver was
increased. Once DC precursors enter the tissue, impair-
ment of appropriate DC trafficking may exacerbate and
prolongs disease course. These data suggest a need for DCs
to form effective granulomas that clear infection, and sug-
gest that inadequate DC function may cause chronic in-
flammation and less effective host resistance. By regulating
the SLC–CCR7 interactions, DCs could be directed to the
appropriate site such as PALT to initiate immune response.
This should minimize the severity of the disease.
In conclusion, we have discovered inflammation-associ-
ated, circulating DC precursors probably distinct from the
previously reported inflammatory monocytes. These pre-
cursors migrate into a peripheral site of inflammation as
quickly as monocytes, mature within developing granulo-
mas, and are likely to trigger the immune response. We
have also established the existence of PALT that may form
immune responses locally in the liver and affect the even-
tual outcome of liver injury. Chemokines regulate this DC
trafficking, and thereby most likely contribute to local dis-
ease outcome. Our in vivo study could extend to other lo-
cal tissues and suggests a role for DCs in chronic granulo-
matous inflammation.48 Dendritic Cell Precursor Traffic into the Liver
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